Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: biostruggle who wrote (31540)	3/29/2005 11:48:55 AM
From: nigel bates	Respond to of 32384

would have to say the risks are much larger than the rewards. Is there anything to stop someone buying the company ? As you point out, it ought be be relatively simple to engineer significant positive cashflow, quite quickly. btw, does anyone a strong view of the likely peak sales for Avinza ? This is key for arriving at a valuation/breakup value, and to say that I don't place much faith in company estimates would be an understatement. $300m ? $200m ? $500m ?? $150m ???